Proliferating cell nuclear antigen cyclin in human transitional cell carcinoma

Area of Science:

• Oncology
• Pathology
• Immunohistochemistry

Background:

• Transitional cell carcinoma of the urinary bladder is a common malignancy.
• Accurate prognostic markers are crucial for effective bladder cancer management.
• The proliferating cell nuclear antigen (PCNA) is a marker of cell proliferation.

Purpose of the Study:

• To evaluate the prognostic value of the PCNA labelling index in bladder transitional cell carcinoma.
• To correlate PCNA index with tumor grade, stage, and patient survival.
• To determine if PCNA index can predict biological aggressiveness.

Main Methods:

• Immunohistochemical staining for PCNA was performed on 56 bladder tumor tissue specimens.
• The PCNA labelling index was calculated by counting labeled cells.
• Tumors were analyzed based on histological grade, stage, and recurrence status.

Main Results:

• PCNA labelling index increased with higher tumor grade (Grade 1: 5.1%, Grade 2: 10.9%, Grade 3: 21.8%).
• Invasive and metastatic tumors showed significantly higher PCNA indices than superficial tumors.
• Patients with PCNA index < 12% had a worse prognosis compared to those with index > 12%.

Conclusions:

• The PCNA labelling index is a valuable quantitative marker for assessing the biological aggressiveness of bladder cancer.
• Elevated PCNA index correlates with higher grade, advanced stage, and poorer prognosis.
• PCNA index provides significant prognostic information but does not predict recurrence in superficial tumors.